Heart failure with reduced ejection fraction

Mignone JL, Alexander KM, Dobbles M, Eberst K, Fonarow GC, Ellenbogen KA. Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients[...]

By sjmartinez • April 2, 2024

Shahid I, Khan MS, Fonarow GC, Butler J, Greene SJ. Bridging gaps and optimizing implementation of guideline-directed medical therapy for heart failure. Prog Cardiovasc Dis.[...]

By sjmartinez • January 21, 2024

Verma A, Fonarow GC, Hsu JJ, Jackevicius CA, Vaghaiwalla Mody F, Nguyen A, Amidi O, Goldberg S, Vetrivel R, Upparapalli D, Theodoropoulos K, Gregorio S,[...]

By sjmartinez • July 27, 2023

Swat SA, Xu H, Allen LA, Greene SJ, DeVore AD, Matsouaka RA, Goyal P, Peterson PN, Hernandez AF, Krumholz HM, Yancy CW, Fonarow GC, Hess[...]

By sjmartinez • June 16, 2023

Ru B, Tan X, Liu Y, Kannapur K, Ramanan D, Kessler G, Lautsch D, Fonarow G. Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions[...]

By sjmartinez • April 18, 2023

Dixit NM, Parikh NU, Ziaeian B, Jackson N, Fonarow GC. Cost-Effectiveness of Comprehensive Quadruple Therapy for Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2023[...]

By sjmartinez • March 10, 2023

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003.[...]

By sjmartinez • October 11, 2022